| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/05/1999 | CA2317812A1 Human growth factor homologs |
| 07/01/1999 | WO1999032645A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/1999 | WO1999032644A2 Prostate cancer gene |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032629A1 Tigirr dna and polypeptides |
| 07/01/1999 | WO1999032626A1 Sigirr dna and polypeptides |
| 07/01/1999 | WO1999032624A1 Human proteins responsible for nedd8 activation and conjugation |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032617A2 Expression cloning in filamentous fungi |
| 07/01/1999 | WO1999032615A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 07/01/1999 | WO1999032610A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999032505A1 MULTIPLE DRUG RESISTANCE GENE atrC OF $i(ASPERGILLUS NIDULANS) |
| 07/01/1999 | WO1999032498A1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 07/01/1999 | WO1999032142A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | WO1999032141A1 Ifnar2/ifn complex |
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | WO1999020747A3 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 07/01/1999 | WO1999019470A3 Gfp-annexin fusion proteins |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | CA2316034A1 Sigirr dna and polypeptides |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315943A1 Multiple drug resistance gene atrc of aspergillus nidulans |
| 07/01/1999 | CA2315942A1 Tigirr dna and polypeptides |
| 07/01/1999 | CA2315888A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | CA2315788A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315240A1 Human proteins responsible for nedd8 activation and conjugation |
| 07/01/1999 | CA2314614A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | CA2311416A1 Prostate cancer gene |
| 06/30/1999 | EP0926239A2 Beta-lipotropin and uses thereof |
| 06/30/1999 | EP0926234A2 Thermostable xylanases |
| 06/30/1999 | EP0926157A1 Protein capable of combining with tbp to form complex, polynucleotide coding for said protein, anti-sense polynucleotide of said polynucleotide, and antibody capable of recognizing said protein |
| 06/30/1999 | EP0925502A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925358A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925305A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 06/30/1999 | EP0925304A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 06/30/1999 | EP0701606A4 Method of enhancing thrombolysis |
| 06/30/1999 | CN1221456A 'alpha' 2 subunit of prolyl-4-hydroxylase, nucleic acid sequences encoding such subunit and methods for producing the same |
| 06/30/1999 | CN1221453A Method for increasing hemoprotein production in filamentous fungi |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221426A Fragments of leptin (OB protein) |
| 06/30/1999 | CN1220997A Recombination human tumour necrofactor and preparation method |
| 06/29/1999 | US5917126 Saccharose phosphate synthetase (SPS), a preparation method and CDNA therefor, and use of the CDNA for modifying SPS expression in plant cells |
| 06/29/1999 | US5917027 Nucleic acids encoding potassium-channel proteins |
| 06/29/1999 | US5917018 Method for producing correctly folded proteins from a mixture of misfolded proteins, e.g. bacterial inclusion-body aggregates |
| 06/29/1999 | US5917017 Diphtheria toxin vaccines bearing a mutated R domain |
| 06/29/1999 | US5917014 Methods of treating inflammation and compositions therefor |
| 06/29/1999 | US5916808 Hybridizing to pre-messenger rna at splice element of native intron, thus creating duplex and permitting splicing; oligonucleotide does not activate rnaase h and blocks mutant splice elements; treatment of beta-thalassemia |
| 06/29/1999 | US5916805 Antithrombotic agent and anti-von Willebrand factor monoclonal antibody |
| 06/29/1999 | US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells. |
| 06/29/1999 | US5916774 D-aminoacylase |
| 06/29/1999 | US5916773 Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components |
| 06/29/1999 | US5916772 The dna encoding saporin and dna encoding the n-terminal extension are selected such that saporin-containing protein is cytotoxic upon internalization by selected cells. |
| 06/29/1999 | US5916771 One advantage of the method of the invention is that cells expressing a single component of the final multi-component protein can be individually selected for one or more desired characteristics, such as a high rate of production. |
| 06/29/1999 | US5916770 Macrophage stimulating protein variant and method for producing the same |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916767 DNA encoding human interleukin-5 receptor |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916561 Monoclonal antibody against CD44v6 |
| 06/29/1999 | US5916558 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 06/29/1999 | CA2062959C Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin |
| 06/29/1999 | CA2000878C Cdnas coding for the subunit of the high-affinity receptor for immunoglobulin e |
| 06/29/1999 | CA1340617C Expression of hepatitis b s and pres2 protiens in methylotrophic yeasts |
| 06/29/1999 | CA1340611C Recombinant alveolar surfactant protein |
| 06/29/1999 | CA1340610C Monoclonal antibody to polymorphic hla determinant-b27 |
| 06/24/1999 | WO1999031266A1 Method for determining and modifying protein/peptide solubility |
| 06/24/1999 | WO1999031257A2 Protein expression in baculovirus vector expression systems |
| 06/24/1999 | WO1999031246A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 06/24/1999 | WO1999031241A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 06/24/1999 | WO1999031239A1 HUMAN Nap1 PROTEIN |
| 06/24/1999 | WO1999031237A1 Apoptosis inhibitory factor |
| 06/24/1999 | WO1999031236A2 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 06/24/1999 | WO1999031234A1 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means |
| 06/24/1999 | WO1999031233A1 Polypeptides, polynucleotides and uses thereof |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031226A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 06/24/1999 | WO1999031140A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/24/1999 | WO1999031139A1 Novel monoclonal antibodies and utilization thereof |
| 06/24/1999 | WO1999031133A1 Novel abc transporter |
| 06/24/1999 | WO1999031132A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS) |
| 06/24/1999 | WO1999031131A2 Mammalian calcitonin-like polypeptide-1 |
| 06/24/1999 | WO1999031130A1 Galanin receptor galr3 and nucleotides encoding same |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1997030158A9 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/24/1999 | CA2730373A1 Treatment of cancer having overexpression of erbb2 with anti-erbb2 antibodies and a hormonal chemotherapeutic agent |
| 06/24/1999 | CA2635158A1 Protein expression in baculovirus vector expression systems |
| 06/24/1999 | CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | CA2326694A1 Galanin receptor galr3 and nucleotides encoding same |